Literature DB >> 4670511

Is there complete cross-resistance of gram-negative bacilli to gentamicin and tobramycin?

C C Crowe, E Sanders.   

Abstract

No cross-resistance between gentamicin and tobramycin was found among 19 recent clinical isolates representing four genera of gram-negative bacilli.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4670511      PMCID： PMC444330          DOI： 10.1128/AAC.2.5.415

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  4 in total

1.  Preliminary studies with nebramycin factor 6.

Authors:  H R Black; R S Griffith
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

2.  Structure of nebramycin factor 6, a new aminoglycosidic antibiotic.

Authors:  K F Koch; J A Rhoades
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

3.  Cross-resistance of Pseudomonas to gentamicin and tobramycin.

Authors:  J L Brusch; M Barza; M G Bergeron; L Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

4.  Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate.

Authors:  W H Traub; E A Raymond
Journal:  Appl Microbiol       Date:  1972-01
  4 in total
  10 in total

Review 1.  Antibacterial Drugs today: II.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.

Authors:  M I Marks; S Hammerberg; G Greenstone; B Silver
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

3.  [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].

Authors:  H H Schassan
Journal:  Infection       Date:  1976       Impact factor: 3.553

4.  Transferrable resistance to tobramycin in Klebsiella pneumoniae and Enterobacter cloacae associated with enzymatic acetylation of tobramycin.

Authors:  B H Minshew; R K Holmes; J P Sanford; C R Baxter
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

5.  Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.

Authors:  R M Kluge; H C Standiford; B Tatem; V M Young; W H Greene; S C Schimpff; F M Calia; R B Hornick
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

6.  Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.

Authors:  K E Price; T A Pursiano; M D DeFuria
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

7.  Aminoglycoside cross-resistance patterns of gentamicin-resistant bacteria.

Authors:  E T Houang; D Greenwood
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

8.  Clinical study of the use of the new aminoglycoside tobramycin for therapy of infections due to gram-negative bacteria.

Authors:  G Jaffe; W Ravreby; B R Meyers; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

9.  Comparative clinical study of tobramycin and gentamicin.

Authors:  J Klastersky; C Hensgens; A Henri; D Daneau
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

10.  Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin.

Authors:  C C Crowe; E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.